179 related articles for article (PubMed ID: 16973595)
1. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.
Gustems M; Borst E; Benedict CA; Pérez C; Messerle M; Ghazal P; Angulo A
J Virol; 2006 Oct; 80(19):9899-904. PubMed ID: 16973595
[TBL] [Abstract][Full Text] [Related]
2. The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells.
Caposio P; Luganini A; Bronzini M; Landolfo S; Gribaudo G
J Virol; 2010 May; 84(9):4481-93. PubMed ID: 20147408
[TBL] [Abstract][Full Text] [Related]
3. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.
Caposio P; Luganini A; Hahn G; Landolfo S; Gribaudo G
Cell Microbiol; 2007 Aug; 9(8):2040-54. PubMed ID: 17419715
[TBL] [Abstract][Full Text] [Related]
4. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication.
Netterwald J; Yang S; Wang W; Ghanny S; Cody M; Soteropoulos P; Tian B; Dunn W; Liu F; Zhu H
J Virol; 2005 Apr; 79(8):5035-46. PubMed ID: 15795289
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
Prösch S; Wuttke R; Krüger DH; Volk HD
Biol Chem; 2002 Oct; 383(10):1601-9. PubMed ID: 12452437
[TBL] [Abstract][Full Text] [Related]
6. Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus.
Chan YJ; Tseng WP; Hayward GS
J Virol; 1996 Aug; 70(8):5312-28. PubMed ID: 8764042
[TBL] [Abstract][Full Text] [Related]
7. The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.
Isern E; Gustems M; Messerle M; Borst E; Ghazal P; Angulo A
J Virol; 2011 Feb; 85(4):1732-46. PubMed ID: 21106746
[TBL] [Abstract][Full Text] [Related]
8. The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.
Boomker JM; The TH; de Leij LF; Harmsen MC
Virus Res; 2006 Jun; 118(1-2):196-200. PubMed ID: 16448715
[TBL] [Abstract][Full Text] [Related]
9. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J
Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925
[TBL] [Abstract][Full Text] [Related]
10. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.
Meier JL; Pruessner JA
J Virol; 2000 Feb; 74(4):1602-13. PubMed ID: 10644329
[TBL] [Abstract][Full Text] [Related]
11. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication.
Meier JL; Keller MJ; McCoy JJ
J Virol; 2002 Jan; 76(1):313-26. PubMed ID: 11739696
[TBL] [Abstract][Full Text] [Related]
12. The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer.
Fickenscher H; Stamminger T; Rüger R; Fleckenstein B
J Gen Virol; 1989 Jan; 70 ( Pt 1)():107-23. PubMed ID: 2543734
[TBL] [Abstract][Full Text] [Related]
13. Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.
Benedict CA; Angulo A; Patterson G; Ha S; Huang H; Messerle M; Ware CF; Ghazal P
J Virol; 2004 Jan; 78(2):741-50. PubMed ID: 14694106
[TBL] [Abstract][Full Text] [Related]
14. TNF receptor independent activation of the cytomegalovirus major immediate early enhancer in response to transplantation.
Zhang Z; Kim SJ; Varghese T; Thomas G; Hummel M; Abecassis M
Transplantation; 2008 Apr; 85(7):1039-45. PubMed ID: 18408586
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human cytomegalovirus replication by overexpression of CREB1.
Chia YL; Ng CH; Lashmit P; Chu KL; Lew QJ; Ho JP; Lim HL; Nissom PM; Stinski MF; Chao SH
Antiviral Res; 2014 Feb; 102():11-22. PubMed ID: 24316029
[TBL] [Abstract][Full Text] [Related]
16. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.
Khan KA; Coaquette A; Davrinche C; Herbein G
J Immunol; 2009 Jun; 182(12):7784-94. PubMed ID: 19494302
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7.
Lee Y; Sohn WJ; Kim DS; Kwon HJ
Eur J Biochem; 2004 Mar; 271(6):1094-105. PubMed ID: 15009188
[TBL] [Abstract][Full Text] [Related]
19. Differentiation-Coupled Induction of Human Cytomegalovirus Replication by Union of the Major Enhancer Retinoic Acid, Cyclic AMP, and NF-κB Response Elements.
Yuan J; Li M; Torres YR; Galle CS; Meier JL
J Virol; 2015 Dec; 89(24):12284-98. PubMed ID: 26423948
[TBL] [Abstract][Full Text] [Related]
20. Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-kappaB.
Kanekiyo M; Itoh N; Kawasaki A; Tanaka J; Nakanishi T; Tanaka K
Toxicol Appl Pharmacol; 2001 Jun; 173(3):146-53. PubMed ID: 11437636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
